Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

Fig. 4

Improver differential gene expression and pathway enrichment analysis. a Improver array tree: blue baseline samples, black post-treatment samples. b Sample genes differentially expressed in improvers between baseline and post-treatment biopsies. c Improver gene signature trends across improver and non-improver samples. Graphs represent Tukey box and whiskers plots. d Pathways differentially expressed in improvers between baseline and post-treatment biopsies

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us